Article Information
History
- August 7, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Filipe B Rodrigues1,†,
- Lauren M Byrne1,†,
- Alexander J Lowe1,
- Rosanna Tortelli1,
- Mariette Heins2,
- Gunnar Flik2,
- Eileanoir B Johnson1,
- Enrico De Vita3,4,
- Rachael I Scahill1,
- Flaviano Giorgini5 and
- Edward J Wild1,*
- 1UCL Huntington’s Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK
- 2Charles River Laboratories, Groningen, the Netherlands
- 3Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, London, UK
- 4Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King’s College London, UK
- 5Department of Genetics and Genome Biology, University of Leicester, Leicester, UK
- ↵* Dr Edward J Wild, e.wild{at}ucl.ac.uk, UCL Huntington’s Disease Centre, University College London, 10-12 Russell Square, London WC1B 5EH
↵† These authors contributed equally as first authors of this study
Posted August 07, 2020.
Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington’s disease
